Arnon P. Kater
ORCID: 0000-0003-3190-1891Also affiliated with Netherlands Center for Occupational Diseases, Oncode Institute, Lymphoma Research Foundation, Lymphoma Study Association, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study”.
Jenny Wu, Thomas J. Kipps, Barbara Eichhorst, Peter Hillmen, James D’Rozario +23 more
Thomas J. Kipps, Barbara Eichhorst, James D’Rozario, Carolyn Owen, Sarit Assouline +16 more
Carolyn Owen, Carol Moreno, George Follows, Talha Munir, Mark-David Levin +16 more
Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Othman Al-Sawaf +19 more
Monia Marchetti, Othman Al‐Sawaf, Ohad Benjamini, Alexey V. Danilov, Matthew S. Davids +24 more
Nienke B. Goedhart, Helga Simon‐Molas, Melanie Mediavilla-Varela, Angimar Uriepero-Palma, Fleur S. Peters +11 more
In-Young Jung, Ziran Zhao, Kimberly Apodaca, Weimin Kong, Stefan Lundh +6 more